Jong Joseph Kim, Chief Executive Officer at INOVIO PHARMACEUTICALS, INC. (INO), sold 100,000 shares at $21.13 ($2.1M) on 2020-07-30, disclosed to the SEC on 2020-07-31.
Open-market sale of $2.1M INO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INO | SELL | 2019-06-04 | $7.6M | — | Filing → |
| INO | SELL | 2019-05-23 | $331K | — | Filing → |
| INO | SELL | 2019-05-17 | $479K | — | Filing → |